Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Systemic Therapy | Research article

Cancer treatment and the risk of cancer death among Aboriginal and non-Aboriginal South Australians: analysis of a matched cohort study

Authors: David Banham, David Roder, Marion Eckert, Natasha J. Howard, Karla Canuto, Alex Brown, for the CanDAD Aboriginal Community Reference Group and other CanDAD Investigators

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Aboriginal and Torres Strait Islander Australians have poorer cancer outcomes than other Australians. Comparatively little is known of the type and amount of cancer treatment provided to Aboriginal and Torres Strait Islander people and the consequences for cancer survival. This study quantifies the influence of surgical, systemic and radiotherapy treatment on risk of cancer death among matched cohorts of cancer cases and, the comparative exposure of cohorts to these treatments.

Methods

Cancers registered among Aboriginal South Australians in 1990–2010 (N = 777) were matched with randomly selected non-Indigenous cases by sex, birth and diagnostic year, and primary site, then linked to administrative cancer treatment for the period from 2 months before to 13 months after diagnosis. Competing risk regression summarised associations of Indigenous status, geographic remoteness, comorbidities, cancer stage and treatment exposure with risk of cancer death.

Results

Fewer Aboriginal cases had localised disease at diagnosis (37.2% versus 50.2%) and they were less likely to: experience hospitalisation with cancer diagnosis, unadjusted odds ratio (UOR) = 0.76; 95%CI = 0.59–0.98; have surgery UOR = 0.65; 95%CI = 0.53–0.80; systemic therapies UOR = 0.64; 95%CI = 0.52–0.78; or radiotherapy, UOR = 0.76; 95%CI = 0.63–0.94. Localised disease carried lower risk of cancer death compared to advanced cases receiving surgery or systemic therapies, SHR = 0.34; 95%CI = 0.25–0.47 and SHR = 0.35; 95%CI = 0.25–0.48. Advanced disease and no treatment carried higher risk of cancer death, SHR = 1.82; 95%CI = 1.26–2.63.

Conclusion

The effects of treatment did not differ between Aboriginal and non-Indigenous cohorts. However, comparatively less exposure to surgical and systemic treatments among Aboriginal cancer cases further complicated the disadvantages associated with geographic remoteness, advanced stage of disease and co-morbid conditions at diagnosis and add to disparities in cancer death. System level responses to improving access, utilisation and quality of effective treatments are needed to improve survival after cancer diagnosis.
Literature
1.
Banham D, Roder D, Keefe D, Farshid G, Eckert M, Cargo M, Brown A, for the CanDAD aboriginal community reference group and other CanDAD investigators. Disparities in cancer stage at diagnosis and survival of aboriginal and non-aboriginal south Australians. Cancer Epidemiol. 2017;48:131–9.PubMedCrossRef
2.
Diaz A, Whop LJ, Valery PC, Moore SP, Cunningham J, Garvey G, Condon JR. Cancer outcomes for aboriginal and Torres Strait islander Australians in rural and remote areas. Aust J Rural Health. 2015;23(1):4–18.PubMedCrossRef
3.
Tervonen HE, Walton R, You H, Baker D, Roder D, Currow D, Aranda S. After accounting for competing causes of death and more advanced stage, do aboriginal and Torres Strait islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales. BMC Cancer. 2017;17(1):398.PubMedPubMedCentralCrossRef
4.
Condon J, Armstong B, Barnes A, Cunningham J. Cancer in indigenous Australians: a review. Cancer Causes Control. 2003;14(2):109–21.PubMedCrossRef
5.
Cunningham J, Rumbold A, Zhang X, Condon J. Incidence, aetiology, and outcomes of cancer in indigenous peoples in Australia. Lancet Oncol. 2008;9:585–95.PubMedCrossRef
6.
Australian Institute of Health and Welfare. Cancer in Aboriginal and Torres Strait Islander peoples of Australia: An overview. Canberra: AIHW; 2013.
7.
8.
Valery P, Coory M, Stirling J, Green A. Cancer diagnosis, treatment, and survival in indigenous and non-indigenous Australians: a matched cohort study. Lancet. 2006;367:1842–8.PubMedCrossRef
9.
Moore S, Green A, Bray F, Garvey G, Coory M, Martin J, Valery P. Survival disparities in Australia: an analysis of patterns of care and comorbidities among indigenous and non-indigenous cancer patients. BMC Cancer. 2014;14(1):517.PubMedPubMedCentralCrossRef
10.
Banham D, Brown A, Roder D. Comorbidities contribute to the risk of cancer death among aboriginal and non-aboriginal south Australians: analysis of a matched cohort study. Cancer Epidemiol. 2018;52(1):75–82.PubMedCrossRef
11.
Tervonen HE, Aranda S, Roder D, Walton R, Baker D, You H, Currow D. Differences in impact of aboriginal and Torres Strait islander status on cancer stage and survival by level of socio-economic disadvantage and remoteness of residence—a population-based cohort study in Australia. Cancer Epidemiol. 2016;41:132–8.PubMedCrossRef
12.
13.
Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17(1):5–19.PubMedCrossRef
14.
Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003;22(1):25–38.PubMedCrossRef
15.
Atkins GT, Kim T, Munson J. Residence in rural areas of the United States and lung Cancer mortality disease incidence, treatment disparities, and stage-specific survival. Ann Am Thorac Soc. 2017;14(3):403–11.PubMedCrossRef
16.
Lai YZ, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin JQ, Myers RE, Li BS, Jiang BH, et al. Effects of Cancer stage and treatment differences on racial disparities in survival from Colon Cancer: a United States population-based study. Gastroenterology. 2016;150(5):1135–46.PubMedPubMedCentralCrossRef
17.
Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomark Prev. 2008;17(8):1950–62.CrossRef
18.
Lee DY, Teng A, Pedersen RC, Tavangari FR, Attaluri V, McLemore EC, Stern SL, Bilchik AJ, Goldfarb MR. Racial and socioeconomic treatment disparities in adolescents and Young adults with stage II-III rectal Cancer. Ann Surg Oncol. 2017;24(2):311–8.PubMedCrossRef
19.
Mahdi H, Han X, Abdul-Karim F, Vargas R. Racial disparity in survival of patients with uterine serous carcinoma: changes in clinical characteristics, patterns of care and outcomes over time from 1988 to 2011. Gynecol Oncol. 2016;143(2):334–45.PubMedCrossRef
20.
Liu FW, Randall LM, Tewari KS, Bristow RE. Racial disparities and patterns of ovarian cancer surgical care in California. Gynecol Oncol. 2014;132(1):221–6.PubMedCrossRef
21.
Akinyemiju TF, Naik G, Ogunsina K, Dibaba DT, Vin-Raviv N. Demographic, presentation, and treatment factors and racial disparities in ovarian cancer hospitalization outcomes. Cancer Causes Control. 2018;29(3):333–42.PubMedPubMedCentralCrossRef
22.
Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Chen J, Dennett E, Cormack D, Cunningham R, Dew K, et al. Survival disparities in indigenous and non-indigenous new Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health. 2010;64(2):117–23.PubMedCrossRef
23.
Lawrenson R, Lao CH, Campbell I, Harvey V, Seneviratne S, Edwards M, Elwood M, Scott N, Kidd J, Sarfati D, et al. Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes. Cancer Causes Control. 2017;28(12):1417–27.PubMedCrossRef
24.
Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R. Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities. Cancer Causes Control. 2015;26(12):1813–24.PubMedCrossRef
25.
Obertova Z, Lawrenson R, Scott N, Holmes M, Brown C, Lao CH, Tyrie L, Gilling P. Treatment modalities for Maori and New Zealand European men with localised prostate cancer. Int J Clin Oncol. 2015;20(4):814–20.PubMedCrossRef
26.
Hall S, D’Arcy Holman C. The influence of socio-economic and locational disadvantage on patterns of surgical care for lung cancer in Western Australia 1982-2001. Aust Health Rev. 2004;27(2):68–79.PubMedCrossRef
27.
Hall SE, Bulsara CE, Bulsara MK, Leahy TG, Culbong MR, Hendrie D, Holman CDJ. Treatment patterns for cancer in Western Australia: does being indigenous make a difference? Med J Aust. 2004;181(4):191–4.PubMedCrossRef
28.
Gibberd A, Supramaniam R, Dillon A, Armstrong BK, O'Connell DL. Lung cancer treatment and mortality for aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit. BMC Cancer. 2016;16:11.CrossRef
29.
Condon J, Cunningham J, Barnes A, Armstrong B, Selva-Nayagam S. Cancer diagnosis and treatment in the Northern Territory - assessing health service performance for indigenous Australians. Intern Med J. 2006;36:498–505.PubMedCrossRef
30.
Whop LJ, Bernardes CM, Kondalsamy-Chennakesavan S, Darshan D, Chetty N, Moore SP, Garvey G, Walpole E, Baade P, Valery PC. Indigenous Australians with non-small cell lung cancer or cervical cancer receive suboptimal treatment. Asia Pac J Clin Oncol. 2017;13(5):E224–31.PubMedCrossRef
31.
Moore SP, Green AC, Garvey G, Coory MD, Valery PC. A study of head and neck cancer treatment and survival among indigenous and non-indigenous people in Queensland, Australia, 1998 to 2004. BMC Cancer. 2011;11:7.CrossRef
32.
Moore SP, Soerjomataram I, Green AC, Garvey G, Martin J, Valery PC. Breast cancer diagnosis, patterns of care and burden of disease in Queensland, Australia (1998–2004): does being indigenous make a difference? Int J Public Health. 2016;61(4):435–42.PubMedCrossRef
33.
Supramaniam R, Gibberd A, Dillon A, Goldsbury DE, O’Connell DL. Increasing rates of surgical treatment and preventing comorbidities may increase breast cancer survival for aboriginal women. BMC Cancer. 2014;14(1):1–9.CrossRef
34.
Cooper GS, Schultz L, Simpkins J, Lafata JE. The utility of administrative data for measuring adherence to cancer surveillance care guidelines. Med Care. 2007;45(1):66–72.PubMedCrossRef
35.
Yerrell PH, Roder D, Cargo M, Reilly R, Banham D, Micklem JM, Morey K, Stewart HB, Stajic J, Norris M, et al. Cancer Data and Aboriginal Disparities (CanDAD)—developing an Advanced Cancer Data System for Aboriginal people in South Australia: a mixed methods research protocol. BMJ Open. 2016;6:12.CrossRef
36.
Brown A, Roder D, Yerrell P, Cargo M, Reilly R, Banham D, Micklem J, Morey K, Stewart H, Investigators ftCACRGaoC. Cancer data and aboriginal disparities project (CanDAD) – an overdue Cancer control initiative. Eur J Cancer Care. 2016;25(2):208–13.CrossRef
37.
Wardliparingga Aboriginal Research Unit. South Australian aboriginal Health Research accord: companion document. Adelaide: South Australian Health and Medical Research Institute; 2014.
38.
Australian Bureau of Statistics: 3238.0.55.001 - Estimates of Aboriginal and Torres Strait Islander Australians, June 2011. In.; 2013.
39.
Banham D, Roder D, Keefe D, Farshid G, Eckert M, Howard N, Canuto K, Brown A. Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non-aboriginal women with breast cancer. BMC Health Serv Res. 2019;19(1):387.PubMedPubMedCentralCrossRef
40.
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, Whelan S. International classification of diseases for oncology, third edition edn. Geneva: World Health Organization; 2000.
41.
Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of Cancer-specific survival rates from population-based data. J Natl Cancer Instit. 2010;102(20):1584–98.CrossRef
42.
Withrow DR, Pole JD, Nishri ED, Tjepkema M, Marrett LD. Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study. Popul Health Metrics. 2017;15(1):24.CrossRef
43.
Young JJ, Roffers S, Ries L, Fritz A, Hurlbut A, National Cancer Institute (eds.): SEER Summary Staging Manual - 2000: Codes and coding instructions,. Bethesda, MD: National Cancer Institute; 2001.
44.
Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples 2015. Canberra: AIHW; 2015.
45.
Sarfati D, Garvey G, Robson B, Moore S, Cunningham R, Withrow D, Griffiths K, Caron N, Bray F. Measuring cancer in indigenous populations. Ann Epidemiol. 2018.
46.
Department of Health and Aged Care. Measuring remoteness: Accessibility/Remoteness Index of Australia. Canberra: Department of Health and Aged Care; 2001.
47.
National Casemix and Classification Centre (NCCC). The International Statistical Classification of Diseases and Related Health Problems Australian Modification (ICD-10-AM). Sydney: NCCC, Australian Health Services Research Institute, University of Wollongong; 2013.
48.
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.PubMedCrossRef
49.
Elsworthy A, Claessen S, Graham B, Guo Y, Innes K, Loggie C, Rankin N, Saad P, Soo I, Tun L: Australian classification of health interventions: ACHI: alphabetic index of interventions. In., 8th edn. Wollongong, Australia: National Casemix & Classification Centre, Australian Health Services Research Institute 2013.
50.
StataCorp: Stata Statistical Software: Release 14.2. In. College Station, TX: StataCorp LP; 2015.
51.
52.
Breslow N, Day N: Statistical methods in Cancer research: volume 1 - the analysis of case-control studies, IARC scientific publications no. 32 edn. Lyon: World Health Organization and the International Agency for Research for Cancer; 1980.
53.
Woodward M: Epidemiology: Study design and data analysis, vol. 62, 2 edn: CRC Press; 2004.
54.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.CrossRef
55.
Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6(2):461–4.CrossRef
56.
Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239–41.CrossRef
57.
Murphy JD, Murphy JD, Nelson LM, Chang DT, Mell LK, Le Q-T. Patterns of Care in Palliative Radiotherapy: a population-based study. J Oncol Pract. 2013;9(5):E220–7.PubMedCrossRef
58.
National Health Performance Committee. National health performance framework report. A report to the Australian Health Ministers’ conference. Brisbane: Queensland Health; 2001.
59.
SCRGSP. (steering Committee for the Review of government service provision): report on government services 2018. Canberra: Productivity Commission; 2018.
60.
Whitehead M. The concepts and principles of equity and health. Copenhagen: World Health Organization; 1990.
61.
Liu JB, Ko CY. Disparities in rectal Cancer: moving from descriptions to solutions. Ann Surg Oncol. 2017;24(2):299–301.PubMedCrossRef
62.
Wotherspoon C, Williams CM: Exploring the experiences of Aboriginal and Torres Strait Islander patients admitted to a metropolitan health service. Australian Health Review 2018:-.
63.
SA Health: South Australian aboriginal Cancer control plan 2016-2021. In Adelaide: Government of South Australia; 2016: 56.
64.
Keech W, Mckivett A, Morey K, Stewart H, Clinch D, Saltmarsh A, Brown A. South Australian chronic disease consortium road map 2017–2021. Adelaide: SAHMRI; 2017.
65.
Cancer Australia. Optimal care pathway for aboriginal and Torres Strait islander people with cancer. Sydney: Cancer Australia; 2018.
Metadata
Title
Cancer treatment and the risk of cancer death among Aboriginal and non-Aboriginal South Australians: analysis of a matched cohort study
Authors
David Banham
David Roder
Marion Eckert
Natasha J. Howard
Karla Canuto
Alex Brown
for the CanDAD Aboriginal Community Reference Group and other CanDAD Investigators
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4534-y

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue

Research article

Group-based, person-centered diabetes self-management education: healthcare professionals’ implementation of new approaches

Research article

Could shared decision making affect staying in hospital? A cross-sectional pilot study

Research article

Process evaluation of specialist nurse implementation of a soft opt-out organ donation system in Wales

Research article

Development and evaluation of a patient passport to promote self-management in patients with heart diseases

Research article

Barriers and facilitators to development and implementation of a rural primary health care intervention for dementia: a process evaluation

Research article

Compliance with standard precaution practices and associated factors among health care workers in Dawuro Zone, South West Ethiopia, cross sectional study